• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

受miR-139-3p调控影响肝癌细胞的进展。

regulated by miR-139-3p regulates the progression of hepatocellular carcinoma cells.

作者信息

Yu Youlin, You Shuqing, Fan Rengen, Shan Xiangxiang

机构信息

Department of Hepatobiliary Surgery, Affiliated Hospital of Shaoxing University, Shaoxing 312000, Zhejiang Province, China.

Department of Pathology, Taizhou First People's Hospital, Taizhou 318020, Zhejinag Province, China.

出版信息

Future Oncol. 2022 Mar;18(8):979-990. doi: 10.2217/fon-2021-0271. Epub 2022 Feb 9.

DOI:10.2217/fon-2021-0271
PMID:35137600
Abstract

This study mainly explores how impacts the progression of hepatocellular carcinoma (HCC). Mature miRNA and mRNA expression data along with the clinical data of HCC were provided by The Cancer Genome Atlas to mine differentially expressed miRNAs and mRNAs. Expression levels of and miR-139-3p in HCC were tested through quantitative real-time PCR. How and miR-139-3p impacted HCC cell activities were detected by Transwell, wound healing and cell proliferation approaches. Whether miR-139-3p could bind to was detected by dual-luciferase assay. This investigation found evidently high levels of in both HCC tissue and cells and its marked association with poor prognosis. Overexpression of could significantly promote the behaviors of HCC cells. In addition, poorly expressed miR-139-3p was inversely associated with . Dual-luciferase method also proved the association. The rescue experiment showed that miR-139-3p regulated cell behaviors in HCC through targeting . Highly expressed was mediated by miR-139-3p to modulate cell behaviors in HCC. It is assumed that is a possible target of HCC for cancer therapy purposes.

摘要

本研究主要探讨[具体内容]如何影响肝细胞癌(HCC)的进展。癌症基因组图谱(The Cancer Genome Atlas)提供了HCC的成熟miRNA和mRNA表达数据以及临床数据,以挖掘差异表达的miRNA和mRNA。通过定量实时PCR检测HCC中[具体内容]和miR-139-3p的表达水平。采用Transwell、伤口愈合和细胞增殖方法检测[具体内容]和miR-139-3p如何影响HCC细胞活性。通过双荧光素酶测定法检测miR-139-3p是否能与[具体内容]结合。本研究发现HCC组织和细胞中[具体内容]水平明显较高,且与预后不良显著相关。[具体内容]的过表达可显著促进HCC细胞的行为。此外,miR-139-3p低表达与[具体内容]呈负相关。双荧光素酶法也证实了这种关联。挽救实验表明,miR-139-3p通过靶向[具体内容]调节HCC细胞行为。miR-139-3p介导高表达的[具体内容]调节HCC细胞行为。推测[具体内容]可能是HCC癌症治疗的一个靶点。

相似文献

1
regulated by miR-139-3p regulates the progression of hepatocellular carcinoma cells.受miR-139-3p调控影响肝癌细胞的进展。
Future Oncol. 2022 Mar;18(8):979-990. doi: 10.2217/fon-2021-0271. Epub 2022 Feb 9.
2
Uridine-cytidine kinase 2 upregulation predicts poor prognosis of hepatocellular carcinoma and is associated with cancer aggressiveness.尿苷-胞苷激酶 2 的上调预示着肝细胞癌的预后不良,并且与癌症的侵袭性有关。
Mol Carcinog. 2019 Apr;58(4):603-615. doi: 10.1002/mc.22954. Epub 2019 Jan 22.
3
miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.miR-1307-3p 通过抑制 DAB2 相互作用蛋白促进肝癌的肿瘤生长和转移。
Biomed Pharmacother. 2019 Sep;117:109055. doi: 10.1016/j.biopha.2019.109055. Epub 2019 Jun 5.
4
MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma.miR-299-3p 通过靶向调控 Sirtuin 5 在肝癌中发挥肿瘤抑制作用。
Biomed Pharmacother. 2018 Oct;106:966-975. doi: 10.1016/j.biopha.2018.06.042. Epub 2018 Jul 14.
5
Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.基于生物信息学分析和实验验证鉴定肝癌中与侵袭转移相关的 microRNAs。
J Transl Med. 2018 Sep 29;16(1):266. doi: 10.1186/s12967-018-1639-8.
6
MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells.miR-128-3p 通过靶向调控 CDC6 抑制肝癌细胞的增殖和转移
Tissue Cell. 2021 Oct;72:101534. doi: 10.1016/j.tice.2021.101534. Epub 2021 Mar 23.
7
miR-144-3p represses hepatocellular carcinoma progression by affecting cell aerobic glycolysis via FOXK1.miR-144-3p 通过影响 FOXK1 来抑制细胞有氧糖酵解从而抑制肝癌进展。
Int J Exp Pathol. 2023 Jun;104(3):117-127. doi: 10.1111/iep.12468. Epub 2023 Feb 19.
8
Up-regulation of miR-10b-3p promotes the progression of hepatocellular carcinoma cells via targeting CMTM5.miR-10b-3p 的上调通过靶向 CMTM5 促进肝癌细胞的进展。
J Cell Mol Med. 2018 Jul;22(7):3434-3441. doi: 10.1111/jcmm.13620. Epub 2018 Apr 24.
9
miR-221-3p regulates hepatocellular carcinoma cell proliferation, migration and invasion via targeting LIFR.miR-221-3p 通过靶向 LIFR 调节肝癌细胞增殖、迁移和侵袭。
Ann Hepatol. 2022 Jan;27 Suppl 1:100567. doi: 10.1016/j.aohep.2021.100567. Epub 2021 Oct 23.
10
MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.微小RNA-655-3p通过调节肝细胞癌中的ADAM10和β-连环蛋白通路发挥肿瘤抑制作用。
J Exp Clin Cancer Res. 2016 Jun 4;35(1):89. doi: 10.1186/s13046-016-0368-1.

引用本文的文献

1
MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities.微小 RNA 与肝细胞癌发病机制:对机制和治疗机会的深入了解。
Int J Mol Sci. 2024 Aug 29;25(17):9393. doi: 10.3390/ijms25179393.
2
A prognostic and immune related risk model based on zinc homeostasis in hepatocellular carcinoma.基于肝细胞癌锌稳态的预后及免疫相关风险模型
iScience. 2024 Mar 2;27(4):109389. doi: 10.1016/j.isci.2024.109389. eCollection 2024 Apr 19.
3
Development and evaluation of a risk score model based on a WNT score gene-associated signature for predicting the clinical outcome and the tumour microenvironment of hepatocellular carcinoma.
基于 WNT 评分基因相关特征的风险评分模型的开发和评估,用于预测肝细胞癌的临床结局和肿瘤微环境。
Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231218179. doi: 10.1177/03946320231218179.
4
The Metabolic and Non-Metabolic Roles of UCK2 in Tumor Progression.尿苷激酶2(UCK2)在肿瘤进展中的代谢和非代谢作用
Front Oncol. 2022 May 20;12:904887. doi: 10.3389/fonc.2022.904887. eCollection 2022.